101117

Hepatitis C Patients with Progress of Disease Severity: Biochemical and Immunological studies

Article

Last updated: 03 Jan 2025

Subjects

-

Tags

Biochemistry

Abstract

Hepatitis C infection has become epidemic with a rapid increase in the number of patients. Hepatitis C has some streaking among which are; most cases don't correlate with the histological of the hepatic biopsies of these patients. The present study aims at investigating some biochemical and immunological aspects among patients varying in degree of disease severity. The study includes 112 subjects; 24 healthy control and 88 CHC patients, grouped as follows: Group I: (control group), Group II: compensated chronic liver disease (without cirrhosis), Group III: decompensated with liver cirrhosis and Group IV: hepatocellular failure; end stage liver.  Results of the present study showed that serum aspartate and alanine transaminases (AST & ALT), gamma glutamyl transferase (GGT), alkaline phosphatase (ALP) activities, total and direct bilirubin, globulin, AST/platelet ratio index (APRI), globulin/platelet ratio, tumor necrosis factor-α (TNF-a), interferon-g (IFN-g), interleukins (lL-2 & IL-4), immunoglobulins (lgA, IgM and IgG), concentrations were increased significantly in all CHC patients groups while, albumin, albumin/globulin ratio (AIG ratio), platelets count, multivariate disriminant analysis (MDA) (based on 4 variables, AST/ALT,platelets, ALP & albumin), were decreased significantly in all CHC patients groups compared to the control group. AST/ALT ratio increased in all groups except Group II. CD4+% was significantly low in Group III and Group IV, while CD8+% decreased significantly in Group II & Group IV. It was concluded that biochemical tests in combination with each other could diagnose serious pathological disorders. Furthermore, immune parameters possibly play a role in the degradation process of the liver. Although, immune system components contribute to the liver injury, they maintain low viral load in advanced stages.

DOI

10.21608/jntas.2020.24286.1019

Keywords

Chronic hepatitis C, liver function, Immune system

Authors

First Name

N.M.

Last Name

Abdallah,

MiddleName

-

Affiliation

Biochemistry Department, Faculty of Science, Ain Shams University

Email

-

City

-

Orcid

-

First Name

Raafat

Last Name

Yousry

MiddleName

M.

Affiliation

NCRRT

Email

raafatyousri@hotmail.com

City

-

Orcid

-

First Name

F.F.

Last Name

Abdel Hamid

MiddleName

-

Affiliation

Biochemistry Department, Faculty of Science, Ain Shams University.

Email

-

City

-

Orcid

-

First Name

M.N.

Last Name

EI- Rouby

MiddleName

-

Affiliation

Department of Cancer Biology, Virology and Immunology Unit, National Cancer Institute, Cairo University, Egypt.

Email

-

City

-

Orcid

-

First Name

S.M.

Last Name

Abdel Fattah

MiddleName

-

Affiliation

Drug Radiation Research Department, National Center for Radiation Research and Technology (NCRRT) Atomic Energy Authority (AEA)

Email

-

City

-

Orcid

-

Volume

8

Article Issue

1

Related Issue

11080

Issue Date

2020-01-01

Receive Date

2020-02-19

Publish Date

2020-07-07

Page Start

67

Page End

95

Print ISSN

2314-8209

Online ISSN

2314-8217

Link

https://jntas.journals.ekb.eg/article_101117.html

Detail API

https://jntas.journals.ekb.eg/service?article_code=101117

Order

7

Type

Original Article

Type Code

632

Publication Type

Journal

Publication Title

Journal of Nuclear Technology in Applied Science

Publication Link

https://jntas.journals.ekb.eg/

MainTitle

Hepatitis C Patients with Progress of Disease Severity: Biochemical and Immunological studies

Details

Type

Article

Created At

22 Jan 2023